Alexandre Schefer Fronza, Ricardo Sabel, Zozula Blind Carrenho Luise, Luis Pollo, de Oliveira Souza Bratti Letícia, Branco Filippin Monteiro Fabíola, Weber Biavatti Maique, Regina Orofino Kreuger Maria
Universidade do Vale do Itajaí, Brazil.
Faculdade Avantis de Ensino Superior, Brazil.
J Ethnopharmacol. 2017 Feb 23;198:262-267. doi: 10.1016/j.jep.2017.01.022. Epub 2017 Jan 15.
Sesquiterpene lactones are organic compounds derived from plants that exhibit anti-inflammatory and antitumor activities being one of the locking mechanisms of action of NF-kB pathway and synthesis of cytokines such as IL-1 and TNF- α.
The overall objective of the present study was to evaluate the antitumor activity of the sesquiterpene lactone diacethylpiptocarphol (DPC) from Vernonia scorpioides (Lam.) Pers. in animal models Ehrlich tumors that has shown antitumor activity.
The antitumor effects of Intraperitonial administration of DPC (5mg/kg/day) were evaluated in Balb/c mice on Ehrlich tumors, and further the body weight, the ascitic cells volume measurement, solid tumor measured and TNF-α level was determinate.
Balb/c mice bearing Ehrlich tumors were treated daily with 5mg/kg/day of the DPC for one week and showed no tumor in the peritoneum after treatment, besides presenting a reduction of TNF-α cytokine. Also the solid tumor reduced size after one week of treatment with DPC.
Sesquiterpene lactone DPC, isolated from Vernonia scorpioides showed antitumor activity because it decreased the size of the solid tumor and abolished the ascitic tumor development, and also did not affect the mice body weight, however the treatment reduced the TNF-α level in mice.
倍半萜内酯是一类源自植物的有机化合物,具有抗炎和抗肿瘤活性,是NF-κB信号通路以及白细胞介素-1和肿瘤坏死因子-α等细胞因子合成的关键作用机制之一。
本研究的总体目标是评估从蝎尾斑鸠菊(Vernonia scorpioides (Lam.) Pers.)中提取的倍半萜内酯二乙酰基匹托卡酚(DPC)在已显示出抗肿瘤活性的艾氏腹水瘤动物模型中的抗肿瘤活性。
在Balb/c小鼠的艾氏腹水瘤模型中评估腹腔注射DPC(5mg/kg/天)的抗肿瘤效果,并进一步测定体重、腹水细胞体积、实体瘤大小以及肿瘤坏死因子-α水平。
携带艾氏腹水瘤的Balb/c小鼠每天接受5mg/kg/天的DPC治疗一周,治疗后腹膜内未发现肿瘤,同时肿瘤坏死因子-α细胞因子水平降低。用DPC治疗一周后实体瘤大小也有所减小。
从蝎尾斑鸠菊中分离出的倍半萜内酯DPC具有抗肿瘤活性,因为它减小了实体瘤的大小,阻止了腹水瘤的发展,且不影响小鼠体重,不过该治疗降低了小鼠体内肿瘤坏死因子-α的水平。